aim
central
nervou
system
pathogen
express
neuraminidas
na
surfac
rat
brain
singl
intracerebroventricular
icv
inject
na
induc
myelin
vacuol
axon
tract
explor
natur
time
cours
role
complement
system
damag
spatiotempor
analysi
myelin
vacuol
perform
optic
electron
microscopi
myelin
basic
proteinposit
area
oligodendrocyt
transcript
factor
posit
cell
quantifi
damag
bundl
neuron
death
affect
axon
tract
assess
fluorojad
b
stain
evalu
role
complement
membran
attack
complex
mac
deposit
damag
bundl
analyz
use
rat
icv
inject
anaphylatoxin
studi
myelin
damag
addit
nainduc
vacuol
studi
rat
differ
degre
complement
inhibit
normal
rat
treat
antibodi
rat
result
stria
medullari
optic
chiasm
fimbria
consist
damag
axon
tract
vacuol
peak
day
na
inject
revert
day
cell
number
damag
tract
unalt
neurodegener
associ
myelin
alter
detect
mac
absent
damag
axon
tract
reveal
immunostain
rat
icv
inject
anaphylatoxin
display
myelin
injuri
complement
system
experiment
constitut
inhibit
nainduc
myelin
vacuol
similar
observ
normal
rat
conclus
microbi
na
induc
moder
transient
myelin
vacuol
caus
either
neuroinflamm
complement
system
activ
introduct
myelin
disord
rang
spontan
inherit
acquir
due
inflammatori
process
autoimmun
disord
infecti
process
toxic
substanc
myelin
vacuol
frequent
patholog
featur
myelin
sheath
although
differenti
neuron
vacuol
occur
encephalopathi
bovin
spongiform
encephalopathi
idea
myelin
vacuol
equival
myelin
degener
exact
sinc
patholog
canavan
diseas
display
conspicu
myelin
vacuol
mild
demyelin
myelin
vacuol
may
occur
least
two
way
frequent
intramyelin
vacuol
produc
myelin
lamella
split
along
intraperiod
line
turn
reopen
extracellular
space
initi
close
format
myelin
mechan
gener
vacuol
fill
unstain
materi
multipl
level
within
myelin
sheath
associ
fluid
accumul
nervou
system
parenchyma
vacuol
caus
inherit
condit
case
canavan
diseas
effect
toxin
mechan
myelin
vacuol
occur
lamella
split
major
dens
line
thu
reopen
intracellular
space
oligodendrocyt
schwann
cell
whatev
etiolog
vacuol
format
progress
myelin
vacuol
demyelin
may
depend
whether
primari
defect
target
myelin
sheath
myelin
cell
time
exposur
induc
agent
gangliosid
sialic
acidcontain
glycosphingolipid
locat
outer
leaflet
plasma
membran
bear
glycan
moieti
extend
extracellular
side
myelinassoci
glycoprotein
mag
transmembran
glycoprotein
specif
myelin
cell
membran
specif
bind
axon
gangliosid
termin
sialic
acid
affin
studi
show
mag
bind
preferenti
latter
present
white
matter
central
nervou
system
cn
mag
locat
innermost
wrap
myelin
direct
contact
axon
surfac
locat
endors
involv
axonmyelin
recognit
neuraminidas
na
exoglucosidas
remov
termin
sialic
acid
glycan
chain
prefer
join
linkag
report
virus
associ
subsequ
myelin
disord
contain
na
coat
singl
intracerebroventricular
icv
inject
clostridium
perfringen
na
within
later
ventricl
lv
rat
induc
partial
ependym
denud
affect
mainli
ipsilater
ventricl
minim
spread
contralater
third
ventricl
recent
neuroinflammatori
event
trigger
na
icv
inject
describ
particip
complement
system
ependym
cell
death
na
demonstr
howev
although
vacuol
axon
tract
describ
detail
studi
alter
axon
tract
perform
role
complement
system
demyelin
disord
issu
debat
precis
function
complement
process
remain
elus
report
speak
protect
role
complement
demyelin
process
other
point
involv
immunemedi
myelin
diseas
even
lack
particip
neuromyel
optica
autoimmun
diseas
cn
display
intramyelin
edema
tissu
vacuol
complement
activ
observ
damag
tissu
hand
sever
fact
suggest
particip
complement
system
nainduc
myelin
vacuol
sialic
acid
remov
human
tumor
cell
red
blood
cell
make
suscept
altern
pathway
activ
format
membran
attack
complex
mac
ii
na
directli
activ
altern
complement
pathway
iii
presenc
na
within
cerebr
ventricl
trigger
activ
complement
system
contribut
ependym
disrupt
present
report
describ
spatial
distribut
time
cours
myelin
vacuol
induc
intraventricular
na
damag
myelin
sheath
oligodendrocyt
cell
neuron
assess
furthermor
role
complement
system
investig
inject
anaphylatoxin
ventricl
normal
rat
also
administr
na
two
rat
model
complement
system
disturb
adult
male
wistar
rat
week
old
g
bodi
weight
charl
river
laboratori
barcelona
spain
use
studi
addit
strain
rat
defici
compon
complement
format
mac
block
use
well
five
six
anim
use
time
experiment
situat
involv
na
inject
unless
otherwis
indic
three
anim
use
control
rat
anim
hous
light
dark
cycl
food
water
avail
ad
libitum
anim
procedur
perform
accord
european
union
anim
anesthet
gkg
bw
fluka
chemika
posit
stereotax
frame
na
c
perfringen
roch
diagnost
dissolv
steril
salin
administr
stereotax
surgeri
right
later
cerebr
ventricl
coordin
bregma
use
anteroposterior
mm
mediolater
mm
dorsoventr
mm
singl
dose
mu
na
inject
aid
pump
rate
min
anim
sacrif
immedi
na
inject
time
h
rest
recov
anesthesia
sacrif
h
h
h
h
day
day
day
day
day
administr
na
time
three
control
rat
icv
inject
salin
process
order
know
whether
neuroinflammatori
reaction
could
induc
myelin
vacuol
four
rat
icv
inject
anaphylatoxin
sigmaaldrich
ref
gener
sever
neuroinflamm
anim
sacrif
h
inject
process
histolog
studi
although
similar
experi
carri
previou
studi
locat
vacuol
specif
site
nainject
rat
could
gone
unnot
order
obtain
system
ventricular
inhibit
complement
compon
strategi
consist
inject
block
antirat
monoclon
antibodi
clone
alexion
pharmaceut
inc
employ
four
anim
use
experi
regimen
administr
previous
describ
initi
intraven
inject
mgkg
bw
follow
h
later
intraperiton
inject
mgkg
bw
accord
publish
data
protocol
result
inhibit
activ
h
first
inject
highest
inhibit
occur
h
second
inject
time
maxim
system
inhibit
antibodi
also
inject
icv
guarante
inhibit
within
ventricular
system
anim
treat
na
icv
inject
simultan
mixtur
na
follow
paramet
outlin
day
treatment
rat
perfus
brain
process
histolog
immunocytochem
studi
anim
anesthet
transcardi
perfus
salin
follow
bouin
fix
brain
remov
immers
fix
h
later
embed
paraffin
wax
sevenmicromet
section
obtain
brain
mount
polyllysinetr
slide
seri
section
along
brain
region
interest
bregma
mm
approxim
obtain
hematoxylineosin
stain
appli
counterstain
section
immunohistochemistri
immunohistochemistri
carri
deparaffin
tissu
section
use
immunoperoxidas
techniqu
primari
antibodi
use
follow
rabbit
antirat
abcam
rabbit
antirat
provid
prof
b
p
morgan
cardiff
univers
rabbit
antimyelin
basic
protein
mbp
zyme
goat
ryd
system
mous
thermo
secondari
antibodi
use
follow
biotinyl
goat
antirabbit
igg
h
l
pierc
biotinyl
hors
antigoat
igg
h
l
vector
mous
antibodi
ultravis
quanto
hrp
system
thermo
fisher
scientif
use
antibodi
dilut
pbt
buffer
bovin
serum
albumin
triton
pb
ph
primari
antibodi
incub
overnight
room
temperatur
rt
secondari
antibodi
incub
min
rt
neg
control
immunostain
consist
equival
section
subject
protocol
omit
primari
antibodi
prior
overnight
incub
primari
antibodi
section
stain
immunoperoxidas
procedur
incub
hydrogen
peroxid
methanol
pb
quench
endogen
peroxidas
activ
section
biotinyl
secondari
antibodi
use
along
avidinbiotin
complex
abc
amplif
method
abc
reagent
prepar
accord
manufactur
instruct
thermo
fisher
scientif
incub
min
peroxidas
activ
reveal
dab
hydrogen
peroxid
incub
perform
moist
chamber
rt
hematoxylineosin
hematoxylin
use
counterstain
immunostain
section
howev
use
weak
immunostain
quantifi
oligodendrocyt
three
icv
nainject
rat
perfus
karnovski
fix
extract
brain
kept
fix
overnight
vibratom
section
thick
use
obtain
piec
mm
mm
differ
brain
area
postfix
osmium
tetroxid
phosphat
buffer
h
dehydr
grade
alcohol
seri
embed
araldit
resin
grade
sigmaaldrich
ref
ultrathin
section
nm
thick
obtain
ultramicrotom
leica
em
use
diamond
knife
diatom
ultra
section
contrast
stain
lead
citrat
uranyl
acet
analyz
use
transmiss
electron
microscop
geol
kv
electron
micrograph
taken
digit
camera
gatan
ref
section
ultrathin
observ
perform
electron
microscopi
core
facil
universidad
de
fluorojad
b
polyanion
fluorescein
deriv
specif
bind
degener
neuron
regardless
whether
death
necrosi
apoptosi
compound
excit
peak
nm
emiss
peak
nm
section
five
rat
h
na
treatment
deparaffin
hydrat
alcohol
convent
manner
includ
step
ethanol
naoh
section
incub
potassium
permangan
solut
min
wash
distil
water
min
incub
solut
fluorojad
b
acet
acid
solut
min
section
wash
distil
water
min
air
dri
min
dri
hotplat
min
dri
immers
xylen
min
mount
eukitt
stain
appli
bouinsfix
paraffin
section
section
cortic
region
directli
damag
inject
needl
use
posit
control
order
assess
time
cours
myelin
vacuol
nainject
rat
mbp
immunoreact
quantifi
ipsilater
contralater
area
anim
sacrif
differ
time
postinject
h
day
day
day
day
day
day
three
section
anim
n
bregma
mm
approxim
chosen
quantif
case
select
section
close
foramen
monro
far
enough
site
inject
avoid
area
surgic
damag
tissu
section
contain
area
interest
includ
stria
medullari
sm
optic
chiasm
howev
fimbria
analyz
close
inject
site
could
affect
damag
needl
histolog
section
two
photograph
taken
one
sm
anoth
optic
chiasm
ipsilater
side
photograph
alway
taken
condit
pictur
process
use
imag
analysi
softwar
visilog
noesi
franc
determin
proport
mbpposit
area
per
imag
afterward
mean
valu
obtain
three
section
studi
anim
consid
percentag
mbpstain
area
anim
total
five
anim
analyz
postinject
time
studi
use
methodolog
higher
vacuol
less
percentag
mbpstain
area
quantit
method
use
determin
whether
oligodendrocyt
damag
natreat
rat
oligodendrocyt
immunocytochem
marker
appli
anim
use
semiquantif
mbp
anim
n
four
section
space
apart
within
region
foramen
monro
rostrocaud
bregma
level
mm
employ
two
photograph
one
sm
optic
chiasm
taken
section
use
object
len
cell
count
refer
quantifi
area
averag
valu
obtain
four
section
studi
anim
five
anim
analyz
postinject
time
studi
differ
time
postinject
na
evalu
anova
signific
level
follow
tukey
post
hoc
test
level
signific
shapirowilk
test
use
ensur
data
met
criteria
normal
allow
use
parametr
statist
leven
test
perform
anova
test
equal
varianc
valu
measur
time
consid
baselin
softwar
spss
statist
ibm
use
analysi
brain
section
stain
hematoxylineosin
vacuolar
spongiform
area
evid
differ
brain
region
day
icv
inject
na
although
occasion
alter
could
observ
earli
h
affect
zone
correspond
myelin
axon
tract
lie
near
inject
ventricl
fimbriafornix
figur
sm
figur
well
distant
myelin
tract
includ
optic
chiasm
figur
tract
consist
affect
natreat
rat
vacuol
correspond
space
gener
adaxon
myelin
axon
could
observ
electron
microscopi
see
myelin
vacuol
mostli
ipsilater
inject
site
although
extend
along
tract
sometim
possibl
observ
mild
vacuol
decuss
tract
contralater
side
vacuol
area
analyz
transmiss
electron
microscopi
order
explor
ultrastructur
featur
hole
control
anim
display
axon
uniform
regular
myelin
sheath
nainject
rat
dilat
irregularli
shape
myelin
sheath
observ
transvers
section
sm
figur
dot
line
enclos
one
myelin
axon
dilat
myelin
sheath
display
inner
caviti
probabl
correspond
vacuol
observ
convent
histolog
techniqu
despit
larger
diamet
dilat
myelin
sheath
appar
similar
observ
nonaffect
axon
axon
untreat
rat
within
vacuol
axon
consist
found
partial
contact
myelin
sheath
arrow
figur
therefor
caviti
seem
aris
space
axon
surfac
innermost
myelin
wrap
rare
axon
show
disorgan
myelin
sheath
found
asterisk
figur
imag
compat
partial
disrupt
interact
innermost
lamella
myelin
axon
membran
concern
time
cours
myelin
vacuol
reach
peak
day
postinject
na
compar
figur
figur
howev
day
number
size
hole
significantli
reduc
figur
day
na
inject
complet
absent
figur
day
sm
fornix
well
farthest
myelin
tract
eg
optic
chiasm
undistinguish
noninject
rat
uniform
hematoxylineosin
stain
absenc
caviti
percentag
mbpposit
area
estim
variou
postinject
time
day
two
consist
vacuol
area
sm
optic
chiasm
figur
second
day
treatment
mbpposit
area
tend
decreas
two
region
studi
figur
day
reduct
signific
compar
control
mbp
level
day
day
mbpposit
area
progress
recov
day
similar
nontreat
rat
figur
cell
quantifi
sm
optic
chiasm
differ
time
postinject
na
figur
signific
variat
found
time
analyz
even
day
vacuol
reach
peak
result
indic
number
oligodendrocyt
modifi
treatment
fluorojad
b
bind
specif
degener
neuron
undergo
necrosi
apoptosi
posit
control
use
section
dorsal
frontal
cortex
contain
neuron
mechan
damag
due
inject
procedur
figur
control
neuron
display
fluoresc
stain
figur
neuron
degener
event
detect
time
analyz
region
studi
includ
myelin
tract
consist
affect
vacuol
figur
c
f
g
area
project
axon
vacuol
bundl
habenula
hippocampu
figur
e
cell
found
subventricular
neurogen
zone
anim
figur
b
highlight
normal
apoptosi
occur
neurogen
nich
howev
cell
detect
region
studi
ie
damag
ependym
epithelium
inject
ventricl
figur
myelin
tract
typic
affect
degener
sm
figur
ependym
cell
neg
sinc
die
necrosi
unravel
whether
activ
complement
might
involv
vacuol
process
observ
nainject
rat
sever
experiment
approach
perform
immunoloc
mac
vacuol
bundl
ii
icv
inject
anaphylatoxin
normal
rat
iii
icv
inject
na
two
differ
rat
model
complement
system
inhibit
none
antibodi
mac
anti
reveal
posit
label
vacuol
axon
bundl
studi
figur
c
thu
suggest
absenc
mac
deposit
vacuol
tract
swollen
lymph
node
use
posit
control
inset
figur
spite
conspicu
neuroinflamm
caus
icv
inject
tract
regularli
suffer
vacuol
upon
na
inject
ie
sm
fimbriafornix
optic
chiasm
appear
complet
normal
rat
anim
mac
inhibit
myelin
vacuol
similar
observ
noninhibit
rat
figur
g
rat
icv
inject
na
induc
vacuol
similar
observ
normal
rat
inject
na
figur
therefor
absenc
mac
prevent
myelin
vacuol
induc
na
could
henc
conclud
complement
mac
involv
etiolog
myelin
vacuol
particular
model
previou
studi
singl
icv
inject
high
dose
na
lv
rat
result
prompt
extens
death
ependym
cell
follow
inflammatori
reaction
myelin
vacuol
longterm
hydrocephalu
sever
effect
lessen
administr
lower
dose
na
result
neuroinflamm
partial
loss
ependym
cell
myelin
vacuol
recent
implic
complement
system
nainduc
ependym
death
report
examin
notic
alter
provok
na
axon
tract
possibl
implic
complement
system
administr
na
lv
elicit
damag
multipl
axon
tract
consist
affect
fimbriafornix
complex
sm
optic
chiasm
ipsilater
side
sever
factor
could
account
recurr
damag
particular
axon
tract
proxim
ventricular
surfac
pial
surfac
ii
vicin
site
icv
inject
iii
way
cerebrospin
fluid
csf
distribut
na
within
ventricular
system
na
inject
lv
reach
brain
parenchyma
distanc
ependym
surfac
pial
surfac
therefor
na
may
directli
act
axon
tract
close
site
inject
affect
axon
tract
display
numer
vacuol
day
na
inject
vacuol
reach
peak
mbpstain
area
lowest
howev
sever
fact
suggest
alter
trigger
myelin
vacuol
may
moder
vacuol
disappear
day
na
inject
suggest
repair
damag
axon
bundl
ii
transmiss
electron
microscopi
show
vacuol
appear
axon
membran
innermost
wrap
myelin
adaxon
vacuol
appar
normal
myelin
sheath
observ
iii
oligodendrocyt
number
affect
vacuol
axon
bundl
iv
neither
neuron
degener
neuron
apoptosi
observ
neuron
nuclei
relat
damag
axon
bundl
concern
etiolog
vacuol
well
establish
myelin
vacuol
occur
least
two
way
split
along
intraperiod
line
call
intramyelin
vacuol
open
extracellular
space
myelin
lamella
axon
membran
myelin
cell
ii
split
lamella
major
dens
line
open
intracellular
space
oligodendrocyt
schwann
cell
intramyelin
vacuol
result
vacuol
locat
multipl
level
within
myelin
sheath
axon
membran
innermost
wrap
myelin
associ
accumul
fluid
nonstain
convent
histolog
method
vacuol
trigger
na
like
repres
intramyelin
vacuol
sinc
vacuol
preferenti
locat
myelin
axon
membran
myelinassoci
glycoprotein
transmembran
glycoprotein
member
siglec
famili
sialic
acidbind
protein
specif
myelin
cell
membran
mag
present
innermost
wrap
myelin
suggest
function
role
axonmyelin
interact
hand
complex
gangliosid
display
termin
sialic
acid
present
neuron
membran
one
strongli
bind
mag
present
white
matter
pretreat
gangliosid
na
abolish
adhes
mag
either
alpha
indic
gangliosidemag
interact
depend
termin
sialic
acid
therefor
hypothes
sialidas
activ
na
may
disrupt
maggangliosid
recognit
henc
axonmyelin
interact
therebi
promot
onset
adaxon
vacuol
na
cytotox
effect
rule
process
mechan
vacuol
give
rise
myelin
abnorm
similar
describ
magnul
mutant
mice
magnul
mice
display
delay
myelin
frequent
myelin
structur
abnorm
similar
alter
found
mice
consid
complet
devoid
complex
gangliosid
howev
myelin
vacuol
describ
mutant
therefor
factor
addit
maggangliosid
disrupt
may
involv
nainduc
vacuol
furthermor
tempor
factor
also
consid
might
contribut
differ
magnul
mutant
maggangliosid
interact
perman
disrupt
nainduc
vacuol
disrupt
transient
similar
intramyelin
vacuol
found
mitochondri
encephalopathi
kearnssayr
syndrom
canavan
diseas
vitamin
anim
toxininduc
injuri
retrovir
infect
although
myelinopathi
author
place
oligodendrocyt
center
diseas
mechan
vacuol
remain
specul
origin
sever
myelin
patholog
multipl
sclerosi
acut
dissemin
encephalomyel
acut
hemorrhag
leukoenceph
relat
neuroinflammatori
process
mostli
autoimmun
demyelin
diseas
accompani
inflamm
cn
wellestablish
notion
multipl
sclerosi
autoimmun
inflammatori
diseas
recent
evolv
toward
idea
neurodegen
diseas
inflammatori
compon
hand
chronic
metabol
mitochondri
encephalopathi
essenti
devoid
neuroinflammatori
compon
nainject
rat
neuroinflammatori
process
import
infiltr
immunocompet
cell
occur
order
explor
whether
neuroinflammatori
reaction
induc
na
caus
myelin
vacuol
anaphylatoxin
icv
inject
rat
produc
proteolysi
compon
complement
function
inflammatori
signal
molecul
therebi
induc
activ
mast
cell
basophil
neutrophil
releas
histamin
proinflammatori
cytokin
addit
display
chemotact
function
therebi
promot
recruit
neutrophil
macrophag
inflammatori
focu
studi
icv
inject
induc
neuroinflammatori
reaction
similar
provok
icv
inject
na
howev
vacuol
axon
bundl
observ
natreat
rat
absent
rat
spite
evid
neuroinflammatori
reaction
result
suggest
neuroinflamm
process
includ
invas
ventricl
periventricular
area
mening
choroid
plexu
immunocompet
cell
caus
myelin
vacuol
event
observ
nainject
rat
function
complement
system
myelinopathi
includ
demyelin
matter
debat
protect
role
complement
demyelin
report
author
suggest
complement
particip
demyelin
role
immunemedi
myelin
diseas
classic
pathway
complement
activ
induc
cleavag
form
anaphylatoxin
upregul
describ
csf
fulmin
case
multipl
sclerosi
anoth
studi
two
factor
involv
complement
activ
clusterin
identifi
csf
sever
patient
multipl
sclerosi
assess
role
complement
system
specif
mac
nainduc
myelin
vacuol
pursu
immunoloc
vacuol
myelin
bundl
evalu
nainduc
vacuol
situat
partial
inhibit
complet
blockad
mac
format
immunostain
mac
label
damag
axon
bundl
howev
mac
label
evid
damag
ependym
cell
partial
inhibit
mac
format
achiev
vivo
block
activ
monoclon
antibodi
administ
system
well
icv
rat
inject
na
display
degre
myelin
vacuol
noninhibit
rat
damag
provok
na
inhibit
could
sever
explan
na
activ
complement
system
downstream
proteolyt
cascad
unlik
vitro
experi
show
nainduc
activ
complement
level
gener
human
serum
ii
mechan
independ
complement
could
account
vacuol
myelin
second
model
vivo
mac
defici
provid
mutant
rat
bear
spontan
delet
gene
prevent
synthesi
henc
block
format
mac
complementmedi
cell
lysi
rat
degre
myelin
vacuol
na
inject
similar
wildtyp
rat
sinc
mac
format
complet
preclud
mutant
rat
detect
immunohistochemistri
result
lead
us
conclud
lytic
pathway
complement
particip
myelin
damag
caus
na
virus
associ
subsequ
myelin
disord
contain
na
coat
case
influenza
viru
parainfluenza
viru
mump
viru
measl
viru
acut
dissemin
encephalomyel
acut
haemorrhag
leucoenceph
inflammatori
demyelin
diseas
aris
within
week
infect
virus
among
virus
bacteria
subacut
scleros
panenceph
also
call
measl
enceph
neuroinflammatori
diseas
trigger
measl
viru
perivascular
inflamm
gliosi
white
matter
irregular
loss
myelin
axon
white
matter
hallmark
diseas
presenc
na
viru
coat
confer
higher
degre
virul
event
brain
infect
nabear
virus
na
could
disturb
axonmyelin
stabil
seen
nainject
rat
thu
na
might
contribut
myelin
disord
associ
certain
viral
infect
summari
singl
icv
inject
na
rat
induc
transient
myelin
vacuol
consist
affect
sm
optic
chiasm
fimbria
locat
vacuol
myelin
sheath
axon
plasma
membran
suggest
disturb
interact
innermost
wrap
myelin
axon
membran
possibl
disrupt
provok
na
interact
mag
gangliosid
level
hypothes
myelin
damag
observ
seem
moder
revert
week
accompani
cell
loss
oligodendrocyt
popul
within
affect
tract
remain
unalt
neurodegener
detect
relat
neuron
nuclei
possibl
caus
vacuol
process
could
neuroinflamm
occur
upon
na
inject
rule
base
result
obtain
icv
inject
anaphylatoxin
final
variou
form
evid
lead
us
discard
particip
complement
system
process
vacuol
induc
na
therefor
direct
sialidas
action
na
myelin
sheath
seem
probabl
caus
vacuol
knowledg
mechan
underli
myelin
disord
caus
nabear
pathogen
cn
may
help
design
effect
therapeut
strategi
